Helicobacter Pylori Infection and Gastric Lymphoma
Overview
Authors
Affiliations
Background: Helicobacter pylori infection is a risk factor for gastric adenocarcinoma. We examined whether this infection is also a risk factor for primary gastric non-Hodgkin's lymphoma.
Methods: This nested case-control study involved two large cohorts (230,593 participants). Serum had been collected from cohort members and stored, and all subjects were followed for cancer. Thirty-three patients with gastric non-Hodgkin's lymphoma were identified, and each was matched to four controls according to cohort, age, sex, and date of serum collection. For comparison, 31 patients with nongastric non-Hodgkin's lymphoma from one of the cohorts were evaluated, each of whom had been previously matched to 2 controls. Pathological reports and specimens were reviewed to confirm the histologic type of the tumor. Serum samples from all subjects were tested for H. pylori IgG by an enzyme-linked immunosorbent assay.
Results: Thirty-three cases of gastric non-Hodgkin's lymphoma occurred a median of 14 years after serum collection. Patients with gastric lymphoma were significantly more likely than matched controls to have evidence of previous H. pylori infection (matched odds ratio, 6.3; 95 percent confidence interval, 2.0 to 19.9). The results were similar in both cohorts. Among the 31 patients with nongastric lymphoma, a median of six years had elapsed between serum collection and the development of disease. No association was found between nongastric non-Hodgkin's lymphoma and previous H. pylori infection (matched odds ratio, 1.2; 95 percent confidence interval, 0.5 to 3.0).
Conclusions: Non-Hodgkin's lymphoma affecting the stomach, but not other sites, is associated with previous H. pylori infection. A causative role for the organism is plausible, but remains unproved.
Seroprevalence in Rheumatoid Arthritis Patients with Interstitial Lung Disease.
Oka S, Higuchi T, Furukawa H, Shimada K, Okamoto A, Fujimori M Biomark Insights. 2024; 19:11772719241297171.
PMID: 39640205 PMC: 11618895. DOI: 10.1177/11772719241297171.
Steinbrecher O, Kiesewetter B, Dolak W, Brand R, Simonitsch-Klupp I, Raderer M Hematol Oncol. 2024; 43(1):e70007.
PMID: 39624879 PMC: 11612847. DOI: 10.1002/hon.70007.
O-GlcNAcylation: Crosstalk between Hemostasis, Inflammation, and Cancer.
Vasquez Martinez I, Perez-Campos E, Perez-Campos Mayoral L, Cruz Luis H, Pina Canseco M, Zenteno E Int J Mol Sci. 2024; 25(18).
PMID: 39337387 PMC: 11432004. DOI: 10.3390/ijms25189896.
Haslbauer J, Wiegand C, Hamelin B, Ivanova V, Menter T, Savic Prince S Infect Agent Cancer. 2024; 19(1):33.
PMID: 39068468 PMC: 11282790. DOI: 10.1186/s13027-024-00597-0.
Islam J, Yano Y, Okamoto A, Matsuda R, Shiraishi M, Hashimoto Y Sci Rep. 2024; 14(1):12066.
PMID: 38802465 PMC: 11130178. DOI: 10.1038/s41598-024-62200-1.